echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > "Grease" heart, "drug" to say things!

    "Grease" heart, "drug" to say things!

    • Last Update: 2020-07-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Various drug options for blood lipid abnormalities!Pharmacist I originally eat is Shuftan Drthis time to me opened ale suftan specifications is a piece of ale is a piece before I eat Shufftan is a day a piece of the doctor also let me eat a tablet is not too big? First, let's look at two drugs: "Shuftan" is a generic name for the resuvastatin calcium tablet "Ale" and the generic name is the Atavastatin calcium tabletBoth are statins for drug indications as lipid abnormalitiesWhat do you mean blood lipid abnormalities? Blood lipid abnormality refers to the abnormal levels of one or more lipids in the plasma where the metabolism of lipids occurs, the fat metabolism or the transport of abnormal plasma, including total plasma cholesterol (), triamide glycerin (), low-density lipoprotein () and other levels are too high or HDL () levels are too lowThe manifestations are: serum (total cholesterol, triglycerides, and, high or low levels)Asymptomatic blood lipid abnormalities themselves are the main risk factors for hypertension, coronary heart disease, atherosclerosis and cerebrovascular accidentsStatin dose equivalent table from the above table can be seen that the patient originally took the risuvastatin calcium tablets suftan corresponding equivalent atavastatin calcium tablets ale) dose for although the drug dose increased but the chemical composition, drug body metabolism and conversion degree, etcdifferent finally achieved by the two final two results in the sameIt is therefore appropriate for doctors to make changes to treatment regimens based on the patient's specific condition and lack of primary medicinesNote: Patients may not change the treatment plan on their own needs to be under the guidance of a doctor to use reasonable medicationDo you pay attention to the lipid-in-the-drug and these points? First, to distinguish the type of selection of drugs for clinical application of the main lipid drug lipid abnormality should first take control of diet, increase exercise and other measures to improve lifestyle followed by the use of drugsLipid-regulating drugs are mainly divided into two categories: reducing total cholesterol and triglycerides: total cholesterol-lowering mainly includes statins and bile acid chelating agentsTriglycerides include Bettes, niacins and sea fish oilsSecond, the dose should be taken in accordance with the instructions to take the amount of lipid-regulating drugs is usually safe adverse reaction incidence is very lowIt can disappear on its own even after an adverse reaction has been discontinuedHowever, some patients in pursuit of efficiency and take more than the prescribed incidence of adverse reactions to the dose will increase significantly and the prognosis is poor Third, drug-eating interactive drugs: statins and batite combination is a double-edged sword two can undoubtedly enhance the efficacy but may increase the probability of transverse myolytic ationolytic disease can be used in combination with patients with statins or Bate drugs can not control the disease, but need to closely monitor myoenzyme and liver enzymes from small doses to start with morning-based bat, late statin drug treatment to avoid significantly increased blood concentration Food: during the use of lipid-intake should also pay attention to avoid a large number of grapefruit, orange peel, Buddha hands, liquor These foods can aggravate adverse reactions to lipid-in-the-drug drugs Grapefruit juice contains blood concentrations of drugs that inhibit cytochrome metabolism Fourth, some people to disable or carefully use pregnant and lactating women disabled over the age of the elderly, diabetes, liver and kidney dysfunction should be used with caution V Regular monitoring of blood lipids and safety indicators during the administration of drugs should pay attention to every month to review blood lipid levels and monitor safety indicators The main monitoring indicators were serum glutamate transaminase (), gustula transaminase (), myophosphatekinase () If transaminase is higher than normal value times, creatine kinase is higher than normal value times must stop the drug Life about blood lipid reduction of a common common misconception blood lipid abnormality and diet and lifestyle have a close relationship to prevent the occurrence of high blood lipids the first thing is to manage their mouths While taking the medicine, the patient still needs to adhere to a reasonable diet and cultivate good living habits Control the proportion of the composition of the nutrient elements based on meeting the needs of the daily essential nutrients Foods with low cholesterol content, especially vegetables with more fiber, can reduce the absorption of cholesterol in the intestines You should also lose weight and exercise properly
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.